ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr | ₹3,935 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2023 | ₹5,653 Cr |
Mar2022 | ₹5,306 Cr |
Mar2021 | ₹5,393 Cr |
Mar2020 | ₹4,606 Cr |
Mar2019 | ₹3,935 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹5,653 Cr | 6.54 | |
Mar2022 | ₹5,306 Cr | -1.62 | |
Mar2021 | ₹5,393 Cr | 17.10 | |
Mar2020 | ₹4,606 Cr | 17.06 | |
Mar2019 | ₹3,935 Cr | - |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹20,175.1 Cr | 3.6% | 2.1% | 78.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | 3.6% |
2.1% |
78.4% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses